Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether the four imported acne products were classifiable as medicaments under Heading 3004 or as beauty or skin-care preparations under Heading 3304. (ii) Whether additional duty of customs on the Category-I products was to be levied on MRP-based value under the proviso to section 3(2) of the Customs Tariff Act, 1975. (iii) Whether additional duty of customs on the Category-II products packed into kits after import was also to be levied on MRP-based value rather than transaction value.
Issue (i): Whether the four imported acne products were classifiable as medicaments under Heading 3004 or as beauty or skin-care preparations under Heading 3304.
Analysis: The classification turned on whether the products had a primary therapeutic or prophylactic use, or whether any therapeutic effect was merely subsidiary to their cosmetic or skin-care function. The product labelled as revitalizing toner was found to be a cleansing preparation without active medicinal ingredient and therefore remained within Heading 3304. The other three products contained Benzoyl Peroxide or Sulphur in substantial concentration, carried drug-style labelling and warnings, were supported by drug-control documentation, and were shown by pharmacological material to be recognized acne-treatment substances. In such a setting, the exclusion for preparations of Chapter 33 with only subsidiary therapeutic value did not apply.
Conclusion: The revitalizing toner was classifiable under Heading 3304, while the renewing cleanser, repairing lotion, and refining mask were classifiable under Heading 3004. This issue was partly in favour of the assessee.
Issue (ii): Whether additional duty of customs on the Category-I products was to be levied on MRP-based value under the proviso to section 3(2) of the Customs Tariff Act, 1975.
Analysis: The proviso to section 3(2) applies where imported goods are required to declare retail sale price on the package and the like article is covered by a section 4A notification. The medicinal products were treated as non-scheduled formulations intended for sale, attracting clause 15 of the Drugs (Prices Control) Order, 1995 and the corresponding MRP declaration requirement. Once MRP declaration was statutorily required, valuation for additional customs duty had to follow the retail-sale-price mechanism with the applicable abatement under the section 4A notification.
Conclusion: Additional duty on the Category-I products was payable on MRP-based value with the notified abatement. This issue was in favour of the Revenue.
Issue (iii): Whether additional duty of customs on the Category-II products packed into kits after import was also to be levied on MRP-based value rather than transaction value.
Analysis: The fact that the imported items were later placed in kits did not remove their identity as goods intended for sale. The imported medicaments remained non-scheduled formulations, and the statutory obligation to declare MRP attached at the stage of import. The attempt to treat the importer as an industrial consumer under the packaged commodities rules was rejected because the goods were not inputs used for production in the ordinary sense. The valuation mechanism therefore remained the same as for Category-I goods.
Conclusion: Additional duty on the Category-II products was also payable on MRP-based value and not on transaction value. This issue was in favour of the Revenue.
Final Conclusion: The ruling accepted medicament classification only for the three products containing active therapeutic ingredients, but upheld MRP-based valuation for additional customs duty in respect of both categories of goods.
Ratio Decidendi: A skin-care preparation is classifiable as a medicament when its therapeutic or prophylactic effect is primary and substantial, and imported non-scheduled formulations intended for sale attract MRP-based customs valuation where the applicable law requires retail price declaration on the package.